Transforming Growth Factor-β Modulates Cancer Stem Cell Traits on CD44 Subpopulations in Hepatocellular Carcinoma

Area of Science:

• Hepatocellular carcinoma (HCC) research
• Cancer stem cell (CSC) biology
• Molecular signaling pathways

Background:

• Hepatocellular carcinoma (HCC) is a major cancer with growing interest in targeting cancer stem cells (CSCs).
• CD44 isoforms are key CSC markers in HCC, linked to epithelial-mesenchymal transition (EMT) induced by transforming growth factor-beta (TGF-β).
• The precise interplay between CSC traits, CD44 isoforms, and TGF-β's effects on CD44 subpopulations in HCC is not fully understood.

Purpose of the Study:

• To investigate how TGF-β influences proteomic changes and CSC traits in HCC subpopulations expressing CD44 standard (CD44std) and CD44 variant 9 (CD44v9).

Main Methods:

• Treatment of SNU-423 HCC cells with TGF-β.
• Morphological assessment and flow cytometry for CD44 subpopulations.
• Proteomic analysis focusing on signaling pathways.
• Validation of gene expression (Sox2, Nanog) and functional assays (colony/spheroid formation, migration, invasion).

Main Results:

• TGF-β induced morphological changes, reduced CD44v9+ cells, and altered CD44std expression.
• Proteomic analysis revealed significant changes in the mitogen-activated protein kinase (MAPK) pathway.
• TGF-β upregulated CD44std and downregulated CD44v9 expression, modulated Sox2/Nanog, and differentially affected CSC traits.
• TGF-β promoted EMT, enhancing migration and invasion in both subpopulations and adhesion in CD44v9 cells.

Conclusions:

• TGF-β dynamically modulates CD44std and CD44v9 subpopulations in HCC, influencing CSC traits via MAPK signaling.
• Understanding these interactions is crucial for developing targeted therapies for HCC.
• This study clarifies the role of CD44 isoforms in TGF-β-mediated CSC regulation in HCC.